Heart patients: which statin combo keeps cholesterol lower longer?
NCT ID NCT05910476
First seen Dec 10, 2025 · Last updated May 15, 2026 · Updated 26 times
Summary
This study compares two different cholesterol-lowering drug combinations (rosuvastatin/ezetimibe vs. atorvastatin/ezetimibe) in 200 adults who have received a heart stent. The goal is to see which combo better keeps LDL cholesterol below 55 mg/dL and causes fewer side effects like muscle pain. Participants will be followed for one year.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Yongin Severance Hospital
Yongin, Gyeonggi-do, 16995, South Korea
Conditions
Explore the condition pages connected to this study.